Christopher Prashad | Public Health | Best Researcher Award

Dr. Christopher Prashad | Public Health | Best Researcher Award

York University, Canada

Author Profile đź“š

Orcid

🔍 Summary

Dr. Christopher Prashad is a PhD candidate in Mathematics and Statistics, specializing in Data Science for Public Health at York University. With a strong foundation in advanced quantitative research, including time series analysis, machine learning, stochastic simulation, and probabilistic programming, Dr. Prashad excels in transforming complex data into actionable insights. He has a proven track record of collaborating with academic and industry teams, effectively communicating technical concepts, and is eager to apply his skills in Data Science to drive meaningful decision-making.

🎓 Education

Dr. Prashad is currently pursuing his PhD in Mathematics and Statistics – Data Science for Public Health at York University (expected June 2025). He is also completing a MicroMasters in Finance from MIT Sloan School of Management (expected January 2025). He holds a Master’s degree in Mathematics and Statistics from York University and a Bachelor of Science in Mathematics and Chemistry from the University of Toronto.

đź’Ľ Professional Experience

Dr. Prashad has worked as a Mathematics for Public Health Researcher at York University–Sanofi Pasteur (2022–2024), where he collaborated with pharmaceutical companies and public health organizations to drive evidence-based policies and modeling initiatives. Prior to this, he worked as a Statistician at Western University (2014–2019), conducting longitudinal studies to assess the impact of STEM education programs. He has also served as a Course Director for Statistical Methods in Health Studies at York University (2018–2019), delivering lectures and tutorials while fostering student engagement in applied statistics.

đź“š Academic Projects & Presentations

Dr. Prashad has contributed to several notable academic projects, such as Multiperiod Forecasting of Epidemic Prevalence using machine learning to predict the spread of flu-like illnesses, and Stochastic Threshold Analysis for SIRS Model, where he applied advanced mathematical techniques to epidemic modeling. He also analyzed Indexed GIC Investment Products using stochastic volatility models, presenting his findings to industry leaders in finance.

đź’» Technical Skills

Dr. Prashad is proficient in a wide range of software and analytical tools, including Python, R, MATLAB, SQL, SPSS, and C. He specializes in Time Series Analysis, Stochastic Simulation, Machine Learning, Multivariate Statistics, and Probabilistic Programming, with expertise in Bayesian Methods, Optimization, and Data Visualization.

👩‍🏫 Teaching Experience

As a Course Director at York University, Dr. Prashad designed and delivered lectures on statistical methods in health studies, supported diverse student learning needs, and contributed to collaborative course design and student development.

🔬 Research Interests

Dr. Prashad’s research interests lie at the intersection of data-driven public health modeling, machine learning in healthcare, and mathematical epidemiology, with a particular focus on applying quantitative analysis to solve public health challenges.

 

đź“– Top Noted Publications

Stochastic Threshold Analysis for Mean-Reverting SIRS Model
    • Authors: Dr. Christopher Prashad (and collaborators)
    • Journal: Journal of Theoretical Biology
    • Year: 2024
Problems and Solutions in Modern Finance, Financial Accounting, Mathematical Methods for Quantitative Finance, and Derivatives Markets
    • Authors: Dr. Christopher Prashad (and collaborators)
    • Journal: Independent publication
    • Year: 2024
Assessing the Impact of Community Mobility on COVID-19 Dynamics
    • Authors: Dr. Christopher Prashad (and collaborators)
    • Journal: PLOS Computational Biology
    • Year: 2024
State-Space Modelling for Infectious Disease Surveillance Data: Stochastic Simulation Techniques and Structural Change Detection
    • Authors: Dr. Christopher Prashad (and collaborators)
    • Journal: Journal of Infectious Disease Modelling, Primer Articles
    • Year: 2024
State-Space Modelling for Infectious Disease Surveillance Data: Dynamic Regression and Covariance Analysis
    • Authors: Dr. Christopher Prashad (and collaborators)
    • Journal: Journal of Infectious Disease Modelling, Primer Articles
    • Year: 2024

Chitchamai Ovatlarnporn | Drug development | Best Researcher Award

Assist Prof Dr. Chitchamai Ovatlarnporn | Drug development | Best Researcher Award

Assist Prof Dr. Chitchamai Ovatlarnporn at Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hatyai, Songkhla, Thailand

👨‍🎓Professional Profiles

🧑‍🏫 Early Academic Pursuits

Dr. Chitchamai Ovatlarnporn’s academic journey began with a solid foundation in pharmacy. She earned her Bachelor of Pharmacy (Second Honours) from Songkhla University in 1990. Building on this, she went on to pursue higher education internationally, receiving a Master’s Degree in Biotechnology from the University of Kent at Canterbury in 1993, and later obtaining a Ph.D. in Chemistry from the University of Ottawa in 2000. This educational progression laid the groundwork for her distinguished career in pharmaceutical sciences, particularly in the areas of drug delivery systems, medicinal chemistry, and biotechnology.

đź’Ľ Professional Endeavors

Dr. Ovatlarnporn’s professional career has been deeply intertwined with both academic and research excellence. She holds a prominent position as an Associate Professor at the Faculty of Pharmaceutical Sciences, Prince of Songkla University (PSU), Thailand. In addition to her teaching responsibilities, she is a pivotal figure in the Department of Pharmaceutical Chemistry at PSU, where she focuses on cutting-edge pharmaceutical research, particularly related to drug development and delivery systems. Over the years, she has successfully combined her roles as an educator, researcher, and consultant in various national and international research projects.

Her expertise extends to consulting for product development and research with projects like Move World Together and Tech2BiZ, reflecting her dynamic role in fostering innovation within the pharmaceutical and biotechnology industries.

🔬 Contributions and Research Focus

Dr. Ovatlarnporn’s research is diverse and far-reaching, focusing primarily on drug delivery systems, pharmaceutical chemistry, and biotechnology. One of her major research interests lies in the development of nanotechnology-based drug delivery systems, such as the preparation and evaluation of nanomicelles for enhanced solubility and bioavailability of poorly water-soluble drugs like curcumin and resveratrol.

She has also made significant contributions to pharmacological research, investigating the antioxidant, anti-inflammatory, and anticancer properties of various medicinal plants and their bioactive compounds. Her work also includes genetic engineering, the synthesis of novel compounds, and the utilization of biopolymers for targeted drug delivery systems, particularly in colon-specific drug delivery.

🌍 Impact and Influence

Dr. Ovatlarnporn’s work has had a significant impact on both the academic and pharmaceutical industries. Her research on tetrhydrocurcumins, curcumin derivatives, and chitosan-based drug delivery systems has opened new avenues for cancer therapy, chronic disease management, and sustainable biopharmaceutical innovations.

Her published works are frequently cited in high-impact journals such as Food Bioscience, Journal of Drug Delivery Science and Technology, and Molecules, making her an influential researcher in her field. Her studies on natural compounds such as Viola stocksii and Tiliacora triandra have advanced the scientific understanding of their pharmacological potentials, contributing to the growing body of knowledge in natural product-based drug development.

đź“š Academic Cites & Recognition

Dr. Ovatlarnporn has authored and co-authored numerous peer-reviewed papers, making significant contributions to the fields of medicinal chemistry, pharmaceutical biotechnology, and drug delivery systems. Notable publications include:

  • “Evaluation of the Anti-Inflammatory, Antioxidant, and Cytotoxic Potential of Cardamine Amara L.” published in Frontiers in Chemistry (Impact Factor: 5.5).
  • “Insights into the remarkable attenuation of hen egg white lysozyme amyloid fibril formation mediated by biogenic gold nanoparticles” in the International Journal of Biological Macromolecules (Impact Factor: 8.2).
  • Research on Acanthus ebracteatus and its bioactive properties, published in Molecules.

Her work is widely recognized, with her publications frequently cited by fellow researchers and practitioners in the pharmaceutical sciences, demonstrating her high standing in the global research community.

đź›  Technical Skills

Dr. Ovatlarnporn is proficient in a wide range of technical skills essential to her research work. These include:

  • Nanotechnology and Drug Delivery Systems: Expertise in the preparation and evaluation of drug formulations, particularly nanomicelles and nanoemulsions.
  • Medicinal Chemistry: Deep knowledge of bioactive natural products, their chemical properties, and potential therapeutic applications.
  • Pharmacological Research: Extensive experience in designing and conducting in vitro and in vivo studies to assess the biological activity of plant-based compounds.
  • Analytical Techniques: Skilled in HPLC, GC-MS, NMR, and spectroscopic methods for the identification and quantification of bioactive compounds.
  • Molecular Docking & Computational Studies: Proficient in using in silico models for studying molecular interactions and optimizing drug efficacy.

👨‍🏫 Teaching Experience

As an academic leader at Prince of Songkla University, Dr. Ovatlarnporn has had a profound influence on shaping the next generation of pharmaceutical scientists. Her teaching areas cover various aspects of medicinal chemistry, drug delivery systems, biotechnology, and pharmaceutical technology. She is known for integrating cutting-edge research findings into her curriculum, ensuring that students are exposed to the latest advancements in the field. Her mentoring has inspired numerous graduate students, many of whom have gone on to achieve their own academic and professional successes.

🌱 Legacy and Future Contributions

Looking forward, Dr. Ovatlarnporn is committed to advancing research on nanotechnology and its applications in targeted drug delivery systems. She aims to further her work on sustainable biopharmaceutical innovations and natural product-based therapies, especially in cancer treatment and chronic disease management. Her research in collaboration with industry partners promises to continue to bridge the gap between academic research and commercial product development, ensuring that her contributions have lasting real-world impact.

In the future, Dr. Ovatlarnporn plans to focus on enhancing the bioavailability of natural bioactive compounds, developing more efficient drug delivery platforms, and promoting interdisciplinary collaborations within the fields of pharmacy, biotechnology, and medicine. Her continued dedication to research excellence and academic mentorship ensures her legacy will live on in both the scientific community and the generations of students she has mentored.

Fernando LĂłpez | Healthcare Data Analysis | Excellence in Research

Assoc Prof Dr. Fernando LĂłpez | Healthcare Data Analysis | Excellence in Research

Assoc Prof Dr. Fernando LĂłpez at Hospital Clinico Universitario – Universidad de Valencia, Spain

👨‍🎓  Profile

Early Academic Pursuits 🎓

Dr. Fernando LĂłpez began his academic journey at the Universidad de Cádiz, where he earned his Licenciatura in Medicine and Surgery from 1987 to 1993. His dedication led him to further his education through the Official Doctoral Program in Medicine and Surgery at the Universitat de València, culminating in a doctoral degree awarded with “Sobresaliente cum laude” in 2001.

Professional Endeavors 🏥

Dr. López completed his specialized training in General Surgery and Digestive System Surgery via the MIR program at the Hospital Clínico Universitario de Valencia from 1995 to 2000. He currently serves as an Associate Professor in the Department of Surgery at the Universitat de València, where he has been actively involved since 2011.

Contributions and Research Focus 🔍

Dr. LĂłpez has made significant contributions to surgical research, particularly in the context of the COVID-19 pandemic. He is a co-author of several influential articles addressing surgical risks and outcomes during this crisis, with particular emphasis on the integration of machine learning for risk prediction. His work has been published in leading journals, reflecting his commitment to advancing surgical practices.

Impact and Influence 🌍

His research has garnered considerable attention, with publications in both national and international journals totaling 35, including articles in high-impact publications such as the British Journal of Surgery. His collaborative work with the COVIDSurg Collaborative has had a meaningful impact on surgical protocols during the pandemic.

Academic Cites đź“š

Dr. LĂłpez’s research has resulted in a notable cumulative impact factor of 76.697 across his indexed publications, illustrating the significant reach and influence of his work in the academic community.

Technical Skills ⚙️

As an experienced surgeon, Dr. LĂłpez possesses a robust set of technical skills, particularly in advanced trauma and emergency care. He has been involved in teaching various advanced trauma life support courses and has contributed to international workshops, underscoring his proficiency and commitment to surgical education.

Teaching Experience 👨‍🏫

In addition to his clinical practice, Dr. LĂłpez has extensive teaching experience, having tutored 35 residents in General Surgery and Digestive Surgery. He has organized and led numerous courses and seminars, including advanced trauma support training, reflecting his passion for educating the next generation of surgeons.

Legacy and Future Contributions 🌱

Looking ahead, Dr. LĂłpez aims to continue his research in surgical safety and education, leveraging his experience and expertise to foster advancements in the field. His ongoing commitment to mentoring residents and collaborating on impactful research will undoubtedly leave a lasting legacy in the surgical community.

đź“– Top Noted Publications

 

Characteristics of gastrointestinal stromal tumors associated to other tumors, 2024

Characteristics of gastrointestinal stromal tumors associated to other tumors, 2024

Glasbey, J. C., Nepogodiev, D., COVIDSurg Collaborative. (2021). Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic. British Journal of Surgery, 6, pp. 1-19.

LUCENTUM Project Researchers. (2021). Simplified risk-prediction for benchmarking and quality improvement in emergency general surgery: Prospective, multicenter, observational cohort study. International Journal of Surgery, 97, pp. 1-35.

Glasbey, J. C., Nepogodiev, D., COVIDSurg Collaborative. (2021). Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score. British Journal of Surgery, 6, pp. 1-19.